The long and tortured regulatory-review path for Illumina, Inc. s $7.1 billion acquisition of GRAIL, Inc. demonstrates the current climate of intense global antitrust scrutiny of transactions. The. | May 22, 2023
The long and tortured regulatory-review path for Illumina, Inc.'s $7.1 billion acquisition of GRAIL, Inc. demonstrates the current climate of intense global antitrust scrutiny of transactions.